A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC

NCT07720193 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Extrapulmonary Neuroendocrine Carcinoma

Interventions

DRUG: LBL-024 for Injection
DRUG: Etoposide injection
DRUG: Cisplatin injection
DRUG: Carboplatin injection
DRUG: LBL-024 placebo for injection

Sponsor

Nanjing Leads Biolabs Co.,Ltd

Collaborators

[object Object]